Alignment Healthcare beats Q4 and FY2025 guidance; FY2026 revenue guide $5.14-5.19B

Alignment Healthcare, Inc.

2025-FY EPS reported $0.00 vs consensus -$0.16 ▲ beat (+100.0%)

Q4 revenue $1,012.8M (+44.4% YoY); FY2025 revenue $3,948.7M (+46.1% YoY).
Q4 adjusted EBITDA $11.4M; FY2025 adjusted EBITDA $109.9M; net loss narrows to $1.0M.
Health plan membership 236,300, up 25% YoY; raises 2026 midpoint membership guide by 2,000.
Introduces FY2026 revenue guidance $5.14-5.19B (30-31% growth) and adjusted EBITDA $133-163M.
Medical benefits ratio 87.5% for FY; beat high-end of guidance across all key metrics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.